Pharmacist - Physician Collaborative Approach to the Management of Metabolic Syndrome
This study devised an experimental focused pharmaceutical care program, allowed a clinical pharmacist to work in a physician office to assess and manage patients' metabolic syndrome status and its individual components. This study described the clinical benefits of physician- clinical pharmacist interaction in achieving improved glycemic control, lipid and blood pressure measurements, involving medication, diet, physical activity and patient heath care counseling.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Caregiver)
Primary Purpose: Health Services Research
|Official Title:||Pharmacist - Physician Collaborative Approach to the Management of Metabolic Syndrome|
- Improvements in metabolic syndrome status over the course of this study and absolute mean improvements in individual MS components. [ Time Frame: 6 monthS ] [ Designated as safety issue: No ]
Primary outcomes were specified as:
- Fasting blood glucose < 110 mg/dl.
- Body weight BMI < 25 kg/m2.
- Waist circumference ≤ 102 cm (40 in) in men and ≤ 88 cm (35 inches) in women.
- Serum triglycerides < 150 mg/dl.
- HDL cholesterol ≥40mg/dl in men and ≥50mg/dl in women.
- Blood pressure < 130/85 mm Hg or < 130/80 mm Hg when patients were diabetic.
|Study Start Date:||March 2009|
|Study Completion Date:||November 2009|
|Primary Completion Date:||November 2009 (Final data collection date for primary outcome measure)|
Active Comparator: intervention
pharmacist-physician collaborative approach to manage Metabolic syndrome
Other: Pharmaceutical care services
Patients' metabolic components were assessed and managed collaboratively by focused care plan designed by the clinical pharmacist and approved by the physician.Pharmacist emphasized the change in lifestyle, particularly weight loss and physical activity as a first line therapy for at least 3 months, patients were started on drug therapy when needed as recommended by clinical guidelines.
No Intervention: control
physician only team to manage Metabolic syndrome
A single blinded prospective randomized controlled trial conducted in family medicine outpatients clinics in Jordan. The study enrolled 199 patients met the National Cholesterol Education Program Adult Treatment Panel III (NCEP/ATPIII) criteria for the diagnosis of MS upon the time of enrollment. Patients were randomized into: 110 participants into the intervention arm (pharmacist-physician collaborative approach) and 89 into the control arm (physician only team). Only patients in the intervention arm were provided pharmacist recommendations and pharmaceutical care counseling.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01099306
|family medicine clinic JUH|
|Amman, Jordan, 13046|
|Principal Investigator:||Eman Hammad, MSc||University of Jordan/ Faculty of Pharmacy|
|Study Director:||Abla Al bsoul, PhD||University of Jordan/ Faculty of Pharmacy|